FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2755707929> ?p ?o ?g. }

• W2755707929 endingPage "41" @default.
• W2755707929 startingPage "33" @default.
• W2755707929 abstract "Although somatostatin analogues (SSAs) are recommended as the first-line medical therapy for acromegaly, dopamine agonists (DAs) are also a therapeutic option for treatment. We aimed to assess and compare the efficacies of DAs and SSAs in treating acromegaly in clinical practice. We included 89 patients with acromegaly who took DAs (bromocriptine [BCT], n = 63; cabergoline [CAB], n = 11) or SSAs (n = 15) as a primary medical therapy for more than 3 months in the Seoul National University Hospital. The CAB (45.5%) and SSA (33.3%) groups achieved random GH levels of <2.5 ng/mL and the normal IGF-1 levels were significantly higher than in the BCT group (11.1%) (p = 0.009). We further included all the patients with acromegaly (n = 132) who had taken CAB, BCT, and SSAs as first- or second-line medical therapy. The CAB group showed similar efficacy as the SSA group in terms of the GH and insulin-like growth factor-1 (IGF-1) levels (57.6% for random GH level <2.5 ng/mL, 42.4% for normal IGF-1 levels, 36.4% for both). Logistic regression analysis revealed that medications, age, GH level, or IGF-1 level before medication, hyperprolactinemia, and prior gamma-knife surgery or radiation therapy, did not affect the therapeutic response. High pretreatment GH levels predicted poor treatment outcomes (odds ratio [95% confidence interval] = 0.95 [0.90-0.99]). CAB was effective in treating acromegaly at a relatively lower cost in patients with low pretreatment GH levels." @default.
• W2755707929 created "2017-09-25" @default.
• W2755707929 creator A5006346285 @default.
• W2755707929 creator A5006525512 @default.
• W2755707929 creator A5013068122 @default.
• W2755707929 creator A5039924915 @default.
• W2755707929 creator A5052740970 @default.
• W2755707929 creator A5057474625 @default.
• W2755707929 creator A5058144503 @default.
• W2755707929 creator A5081864835 @default.
• W2755707929 date "2018-01-01" @default.
• W2755707929 modified "2023-10-06" @default.
• W2755707929 title "The efficacy of medical treatment in patients with acromegaly in clinical practice" @default.
• W2755707929 cites W1964737120 @default.
• W2755707929 cites W1974588462 @default.
• W2755707929 cites W1977765716 @default.
• W2755707929 cites W1982049593 @default.
• W2755707929 cites W1982178657 @default.
• W2755707929 cites W1988701052 @default.
• W2755707929 cites W1993154503 @default.
• W2755707929 cites W2004200065 @default.
• W2755707929 cites W2009323605 @default.
• W2755707929 cites W2019246994 @default.
• W2755707929 cites W2022874606 @default.
• W2755707929 cites W2023461773 @default.
• W2755707929 cites W2038754029 @default.
• W2755707929 cites W2040743647 @default.
• W2755707929 cites W2047552400 @default.
• W2755707929 cites W2052430818 @default.
• W2755707929 cites W2056384838 @default.
• W2755707929 cites W2069832931 @default.
• W2755707929 cites W2071541949 @default.
• W2755707929 cites W2071857366 @default.
• W2755707929 cites W2083306937 @default.
• W2755707929 cites W2095591038 @default.
• W2755707929 cites W2111216596 @default.
• W2755707929 cites W2112965103 @default.
• W2755707929 cites W2117270119 @default.
• W2755707929 cites W2155465275 @default.
• W2755707929 cites W2160989555 @default.
• W2755707929 cites W2165663557 @default.
• W2755707929 cites W2165862240 @default.
• W2755707929 cites W2167122489 @default.
• W2755707929 cites W2172067681 @default.
• W2755707929 cites W2318966009 @default.
• W2755707929 cites W2409408110 @default.
• W2755707929 doi "https://doi.org/10.1507/endocrj.ej17-0125" @default.
• W2755707929 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28931779" @default.
• W2755707929 hasPublicationYear "2018" @default.
• W2755707929 type Work @default.
• W2755707929 sameAs 2755707929 @default.
• W2755707929 citedByCount "11" @default.
• W2755707929 countsByYear W27557079292018 @default.
• W2755707929 countsByYear W27557079292019 @default.
• W2755707929 countsByYear W27557079292020 @default.
• W2755707929 countsByYear W27557079292022 @default.
• W2755707929 crossrefType "journal-article" @default.
• W2755707929 hasAuthorship W2755707929A5006346285 @default.
• W2755707929 hasAuthorship W2755707929A5006525512 @default.
• W2755707929 hasAuthorship W2755707929A5013068122 @default.
• W2755707929 hasAuthorship W2755707929A5039924915 @default.
• W2755707929 hasAuthorship W2755707929A5052740970 @default.
• W2755707929 hasAuthorship W2755707929A5057474625 @default.
• W2755707929 hasAuthorship W2755707929A5058144503 @default.
• W2755707929 hasAuthorship W2755707929A5081864835 @default.
• W2755707929 hasBestOaLocation W27557079291 @default.
• W2755707929 hasConcept C126322002 @default.
• W2755707929 hasConcept C134018914 @default.
• W2755707929 hasConcept C151956035 @default.
• W2755707929 hasConcept C156957248 @default.
• W2755707929 hasConcept C2776297358 @default.
• W2755707929 hasConcept C2776856834 @default.
• W2755707929 hasConcept C2777433750 @default.
• W2755707929 hasConcept C2778886798 @default.
• W2755707929 hasConcept C2779064019 @default.
• W2755707929 hasConcept C2779832395 @default.
• W2755707929 hasConcept C2984496839 @default.
• W2755707929 hasConcept C2994510025 @default.
• W2755707929 hasConcept C44249647 @default.
• W2755707929 hasConcept C71315377 @default.
• W2755707929 hasConcept C71924100 @default.
• W2755707929 hasConcept C90924648 @default.
• W2755707929 hasConceptScore W2755707929C126322002 @default.
• W2755707929 hasConceptScore W2755707929C134018914 @default.
• W2755707929 hasConceptScore W2755707929C151956035 @default.
• W2755707929 hasConceptScore W2755707929C156957248 @default.
• W2755707929 hasConceptScore W2755707929C2776297358 @default.
• W2755707929 hasConceptScore W2755707929C2776856834 @default.
• W2755707929 hasConceptScore W2755707929C2777433750 @default.
• W2755707929 hasConceptScore W2755707929C2778886798 @default.
• W2755707929 hasConceptScore W2755707929C2779064019 @default.
• W2755707929 hasConceptScore W2755707929C2779832395 @default.
• W2755707929 hasConceptScore W2755707929C2984496839 @default.
• W2755707929 hasConceptScore W2755707929C2994510025 @default.
• W2755707929 hasConceptScore W2755707929C44249647 @default.
• W2755707929 hasConceptScore W2755707929C71315377 @default.
• W2755707929 hasConceptScore W2755707929C71924100 @default.
• W2755707929 hasConceptScore W2755707929C90924648 @default.

• next